Stephen J. Schuster, M.D.
Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research
Department: Medicine
Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-178
3400 Civic Center Blvd
Philadelphia, PA 19104
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-178
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: (215) 349-5330
Fax: 215-615-5888
Fax: 215-615-5888
Publications
Education:
B.S. (Psychology)
Saint Joseph's University, Philadelphia, PA, 1976.
Laboratory Research Technician, Division of Rheumatology, Hahnemann Medical College and Hospital, Philadelphia, PA, 1977.
M.D.
Jefferson Medical College, Philadelphia, PA, 1981.
Permanent linkB.S. (Psychology)
Saint Joseph's University, Philadelphia, PA, 1976.
Laboratory Research Technician, Division of Rheumatology, Hahnemann Medical College and Hospital, Philadelphia, PA, 1977.
M.D.
Jefferson Medical College, Philadelphia, PA, 1981.
Selected Publications
Daniel J Lewis, Paul L Haun, Sara S Samimi, Carmela C Vittorio, Jennifer Villasenor-Park, Stefan K Barta, Daniel J Landsburg, Jakub Svoboda, Sunita D Nasta, Stephen J Schuster, Alain H Rook, Ellen J Kim: Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome. JAMA Dermatol Dec 2020.Guido Ghilardi, Peter Braendstrup, Elise A Chong, Stephen J Schuster, Jakub Svoboda, Marco Ruella: CAR‐T TREK through the lymphoma universe, to boldly go where no other therapy has gone before. Br J Haematol Nov 2020.
Jie Wang, Katarzyna Urbanska, Prannda Sharma, Reza Nejati, Lauren Shaw, Megan S Lim, Stephen J Schuster, Daniel J Powell Jr: A Novel Approach for the Treatment of T Cell Malignancies: Targeting T Cell Receptor Vβ Families. Vaccines 8(4), Oct 2020.
Qian Zhang, Elena J Orlando, Hong Y Wang, Agata M Bogusz, Xiaobin Liu, Simon F Lacey, Honore T Strauser, Selene Nunez-Cruz, Reza Nejati, Paul Zhang, Sarah Brooks, Christopher Watt, J Joseph Melenhorst, Carl H June, Stephen J Schuster, Mariusz A Wasik: Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenome. Blood 136(17), Oct 2020.
Antonio Cuneo, Anthony R Mato, Gian Matteo Rigolin, Alfonso Piciocchi, Massimo Gentile, Luca Laurenti, John N Allan, John M Pagel, Danielle M Brander, Brian T Hill, Allison Winter, Nicole Lamanna, Constantine S Tam, Ryan Jacobs, Frederick Lansigan, Paul M Barr, Mazyar Shadman, Alan P Skarbnik, Jeffrey J Pu, Alison R Sehgal, Stephen J Schuster, Nirav N Shah, Chaitra S Ujjani, Lindsey Roeker, Ester Maria Orlandi, Atto Billio, Livio Trentin, Martin Spacek, Monia Marchetti, Alessandra Tedeschi, Fiorella Ilariucci, Gianluca Gaidano, Michael Doubek, Lucia Farina, Stefano Molica, Francesco Di Raimondo, Marta Coscia, Francesca Romana Mauro, Javier de la Serna, Angeles Medina Perez, Isacco Ferrarini, Giuseppe Cimino, Maurizio Cavallari, Rosalba Cucci, Marco Vignetti, Robin Foà, Paolo Ghia, GIMEMA, European Research Initiative (ERIC) on CLL, US study group: Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study. Cancer Med 9(22), Sept 2020.
Zheng Zhang, Stephen J Schuster, Simon F Lacey, Michael C Milone, Dimitri Monos, Vijay G Bhoj: Stable HLA antibodies following sustained CD19+ cell depletion implicate a long-lived plasma cell source. Blood Adv 4(18), Sept 2020.
Chaitra Ujjani, Anthony Mato, Brian T Hill, John N Allan, Frederick Lansigan, Ryan Jacobs, Alan Skarbnik, Hande Tuncer, John Pagel, Danielle Brander, Bruce Cheson, Paul Barr, Lindsey E Roeker, Jeffrey Pu, Nirav N Shah, Andre Goy, Stephen J Schuster, Nicole Lamanna, Alison Sehgal, Constantine S Tam, Mazyar Shadman: The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy. Blood Lymphat Cancer Aug 2020.
Daniel J Landsburg, Alexa Koike, Sunita D Nasta, Jakub Svoboda, Stephen J Schuster, Mariusz A Wasik, Gabriel C Caponetti: Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomas. Cancer Immunol Immunother Aug 2020.
Elise A Chong, Lindsey E Roeker, Mazyar Shadman, Matthew S Davids, Stephen J Schuster, Anthony R Mato: BTK Inhibitors in Cancer Patients with COVID-19: "The Winner Will be the One Who Controls That Chaos" (Napoleon Bonaparte). Clin Cancer Res 26(14): 3514-3516, July 2020.
Anthony R Mato, Lindsey E Roeker, Ryan Jacobs, Brian T Hill, Nicole Lamanna, Danielle Brander, Mazyar Shadman, Chaitra S Ujjani, Maryam Sarraf Yazdy, Guilherme Fleury Perini, Javier A Pinilla-Ibarz, Jacqueline Barrientos, Alan P Skarbnik, Pallawi Torka, Jeffrey J Pu, John M Pagel, Satyen Gohil, Bita Fakhri, Michael Choi, Catherine C Coombs, Joanna Rhodes, Paul M Barr, Craig A Portell, Helen Parry, Christine A Garcia, Kate J Whitaker, Allison M Winter, Andrea Sitlinger, Sirin Khajavian, Ariel F Grajales-Cruz, Krista M Isaac, Pratik Shah, Othman S Akhtar, Rachael Pocock, Kentson Lam, Timothy J Voorhees, Stephen J Schuster, Thomas D Rodgers, Christopher P Fox, Nicolas Martinez-Calle, Talha Munir, Erica B Bhavsar, Neil Bailey, Jason C Lee, Hanna B Weissbrot, Chadi Nabhan, Julie M Goodfriend, Amber C King, Andrew D Zelenetz, Colleen Dorsey, Kayla Bigelow, Bruce D Cheson, John N Allan, Toby A Eyre: Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy. Clin Cancer Res 26(14): 3589-3596, July 2020.